Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17521
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChui, Chang Yue-
dc.contributor.authorThomas, Dennis-
dc.contributor.authorTaylor, Simone E-
dc.contributor.authorBonevski, Billie-
dc.contributor.authorAbramson, Michael J-
dc.contributor.authorPaul, Eldho-
dc.contributor.authorPoole, Susan G-
dc.contributor.authorWeeks, Gregory R-
dc.contributor.authorDooley, Michael J-
dc.contributor.authorGeorge, Johnson-
dc.date2018-02-07-
dc.date.accessioned2018-04-24T06:54:31Z-
dc.date.available2018-04-24T06:54:31Z-
dc.date.issued2018-05-
dc.identifier.citationDrug and alcohol review 2018; 37(4): 514-519-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17521-
dc.description.abstractNicotine replacement therapy (NRT) is recommended as a smoking cessation aid for hospitalised smokers. We examined factors associated with NRT use during hospitalisation and after discharge, and NRT uptake when systematically offered free of cost. A nested analysis was conducted using data from a clinical trial that evaluated the effectiveness of a pharmacist-led smoking cessation intervention in 600 hospitalised smokers. NRT was used at least once by 285 (48%) participants during hospitalisation and by 287 (48%) participants during the 12 months post-discharge. Heavy smokers and those who expressed interest in using NRT for their next quit attempt at baseline interview were more likely to use NRT during hospitalisation [odds ratio (OR) 1.94, 95% confidence interval (CI) 1.38, 2.74; OR 2.09, 95% CI 1.48, 2.95] and after discharge (OR 1.70, 95% CI 1.20, 2.41; OR 1.97, 95% CI 1.39, 2.79). Those using six or more medications were more likely to use NRT during hospitalisation (OR 1.65, 95% CI 1.05, 2.61). Post-discharge NRT users were more likely to have been initially admitted for a respiratory or cardiac problem (OR 1.51, 95% CI 1.05, 2.18). When NRT was offered free of cost to a subset of patients (n = 300), 157 (52%) used NRT during hospitalisation. Nicotine dependence and interest in using NRT predicted its use (OR 2.26, 95% CI 1.38, 3.70; OR 2.58, 95% CI 1.58, 4.20). Targeting heavy smokers, those with cardio-respiratory conditions and those interested in using NRT regardless of regimen complexity could improve NRT uptake.-
dc.language.isoeng-
dc.subjecthospitalisation-
dc.subjectnicotine replacement therapy-
dc.subjectsmoking-
dc.subjectsmoking cessation-
dc.titleFactors associated with nicotine replacement therapy use among hospitalised smokers.-
dc.typeJournal Article-
dc.identifier.journaltitleDrug and alcohol review-
dc.identifier.affiliationPharmacy Department, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationCentre for Medicine Use and Safety, Monash University, Melbourne, Australia-
dc.identifier.affiliationDepartment of Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands-
dc.identifier.affiliationSchool of Medicine and Public Health, University of Newcastle, Newcastle, Australia-
dc.identifier.affiliationSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia-
dc.identifier.affiliationClinical Haematology Department, The Alfred, Melbourne, Australia-
dc.identifier.affiliationPharmacy Department, Alfred Health, Melbourne, Australia-
dc.identifier.affiliationPharmacy Department, Barwon Health, Geelong, Australia-
dc.identifier.doi10.1111/dar.12661-
dc.identifier.orcid0000-0003-1978-1591-
dc.identifier.orcid0000-0002-0592-518X-
dc.identifier.pubmedid29411446-
dc.type.austinJournal Article-
local.name.researcherTaylor, Simone E
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptPharmacy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Jul 15, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.